The absorption of a pyrethroid insecticide, cypennethrin, through rat skin has been m easured both in vitro and in vivo. Cypermethrin did not penetrate in vitro through whole skin but did penetrate epidermal m embranes . The in vitro absorption w as influenced by the choice of receptor fluid in the glass diffusion cell. There was good agreem ent between in vivo and in vitro data using 50% aqu eous ethanol , 6% Volpo 20, or total calf serum receptor fluid s. Rat epi-M any pes ticides during m anufacture and use have the potential to contact skin and be absorbed. Consequentl y, part o f the necessary sa fety evaluation involves an assess ment of percutaneous absorption rate. Often , assess ments involve the application of the chemical to the intact skin of a livin g animal (typicall y a rat) and a determination of the extent of absorption made by examin ati on of body Auids and tissues. Su ch methods require substantial technical skill, much time, and the use of live animals [1] . C onfident extrapolati on of the derived data to humans is often ques tionable as the permea bility of hum an skin has been sho wn to be less permea ble than anim al 'skin to a w ide range of chemicals and no ideal animal model has been reported [2] [3] [4] [5] . The monkey has been sho w n to have similar permeability to human skin fo r a sm all range of w ellabsorb ed nitroaromatic compounds [6], but w ith more poorl y absorbed mol ecules significant di fferen ces might be found.
The absorption of a pyrethroid insecticide, cypennethrin, through rat skin has been m easured both in vitro and in vivo. Cypermethrin did not penetrate in vitro through whole skin but did penetrate epidermal m embranes . The in vitro absorption w as influenced by the choice of receptor fluid in the glass diffusion cell. There was good agreem ent between in vivo and in vitro data using 50% aqu eous ethanol , 6% Volpo 20, or total calf serum receptor fluid s. Rat epi-M any pes ticides during m anufacture and use have the potential to contact skin and be absorbed. Consequentl y, part o f the necessary sa fety evaluation involves an assess ment of percutaneous absorption rate. Often , assess ments involve the application of the chemical to the intact skin of a livin g animal (typicall y a rat) and a determination of the extent of absorption made by examin ati on of body Auids and tissues. Su ch methods require substantial technical skill, much time, and the use of live animals [1] . C onfident extrapolati on of the derived data to humans is often ques tionable as the permea bility of hum an skin has been sho wn to be less permea ble than anim al 'skin to a w ide range of chemicals and no ideal animal model has been reported [2] [3] [4] [5] . The monkey has been sho w n to have similar permeability to human skin fo r a sm all range of w ellabsorb ed nitroaromatic compounds [6] , but w ith more poorl y absorbed mol ecules significant di fferen ces might be found.
Du rin g the pas t 20 yea rs, the fac tors governing the percutaneous absorption of chemicals have been studied usin g in vitro meth ods [7] [8] [9] . The rationale fo r this approach is th at the rate of absorption is govern ed by diffusion through the dead, outer layer of the epidermis, the stratum corneum [8] , and th at there is no active transpo rt [1 0]. There have been many publicatio ns describing the utiliza tion of this technique with many different types of chemi cals [11-13] ; how ever, there are fewer publications demonstrating that in vitro results are in agreement with in vivo results [6, [14] [15] [16] .
We have measured the in vivo percutaneous abso rption of the pes ti cide cyperm ethrin after applica tion to rat skin, formul ated in a typical formul ati on. The formul ation was applied in small , finite amounts as mi ght contact a spray o perator under field applica ti on conditions (personal communication fro m Me. G. C hester, IC l pic, 1985).
Manuscript received April 23, 1986 ; accepted fo r publica tion D ece mber 18, 1986. Reprint reques ts to: Robert C. Sco tt, Ph.D ., Imperial C hemica l Industries PLC, Central Toxicology Labo rato ry, Ald erl ey Park, Nr Maccles fi eld , C hes hire SK1 0 4Tj, U. K. dermal m embranes in vitro w ere more than 20 times more permeable to cypermethrin than human epidermal m embranes, indi ca ting that cypermethrin would be less readil y absorbed in humans than in the rat.
The percutaneous absorption in vitro technique usin g epidermal m embranes was successfuJl y used with this lipophilic chemical to predi ct the in vivo absorption in the rat. ] Inv est D eY/natol 89: [142] [143] [144] [145] [146] 1987 The percentage of the appli ed dose absorbed after 8-h contact was measured and , se parately, the profile of the absorption over 24 h. Parallel in vitro studies measured cypermethrin absorption through excised rat and hum an cadaver skin (usin g both whole skin and epidermal membranes). To facilitate analysis and alloW a more accurate assess ment of absorption , [ 14 C] cypermethrin was added to the fo rmulation .
In these studies, we have been prim arily concerned w ith the definiti on of the am ount of chemi cals that might be absorbed in a specific time period and produce general, ra ther than local effects. We have therefore considered a chemical to be absorbed w hen it has ac tuall y diffused throu gh the epidermis.
MA TERIALS AND METH O DS
Radiochemicals (±) a-Cyano-3-phenoxybenzyl ( ± ) cis tra l'lS-3-(2,2,-dichlorovinyl)-2,2-dimeth yl cyclopropanecarboxylate (trivial nam e cy permethrin) was supplied by IC I pic, Plant Protection Division, Fernhurst, Sussex, U . K. as [1 4C]cycloprop-labeled cis-cy permethrin (1. 9 GBq mmo l-I ) and [1 4C)cycloproplabeled tral1s-cy permethrin (2.0 GBq mmol-I ). Bo th isomers we re purified by high-performance liquid chromatog raphy to a radi ochemical purity of > 97% as determined by thin-la yer chromatography. The isomers were mixed to give a cis-cy permethrin to trans-cypermethrin rati o of 50. 2 : 49. 8 . T wo cypermethrin dosin g solutions were prepared; a concentrate fo rmulation of 359 g/liter and an oil based spray dilution of 29 g/liter. The dosing solutions were monitored fo r stability throughout the stud y and at all tim es the radiochemical purity w as >97%.
Tritiated water w as supplied by Amersham Internati onal, Buckinghamshire, U .K. and w as diluted for use to 0.1 MBq ml -I .
In Vitro Studies Human abdominal skin was obtained fr om autopsy and the subcutaneous fat removed . Human epidermal sheets were separated fro m full-thickn ess skin by immersing in water at 60°C for 45 s and gently peelin g aw ay the epidermis [17] . Excised skin fr o m the do rsolumbar region of 4-to 5-weekold rats (Alpkl AP strain , Wistar derived) was used . Rat epidermal sheets w ere prepared by soakin g in 2 M N aBr solution before 0022-202X /87/$03. 50 Copyri ght © 1987 by The Society fo r In ves ti gati ve Derm ato logy, Inc. gently peeling away the epidermis [17) . Membranes that were not used immediately were wrapped in aluminium foil and stored at 4°C for up to 2 weeks.
Donor Chamber
Both whole skin and epidermal membranes were mounted in horizontal glass diffusion cells and exposed to ambient conditions (Fig 1) . The exposed area of tissue between the donor and receptor chambers was 2.54 cm 2 Prior to the application of the formulations the integrity of each membrane was assessed by determining the permeability to tritiated water [11] over a 6-h period. Cells that had intact membranes were then left overnight with a small volume of saline (0.5 mJ) in the receptor chamber (capacity 4.5 ml) to maintain a high relative humidity, and the epidermal surface left exposed to the atmosphere. Test chemicals were then applied to the intact epidermal membranes on the next day.
In the first series of in vitro experiments, the percutaneous absorption of [1 4C]cypermethrin from the concentrate and spray dilution formulations through human and rat whole skin and epidermal membranes during an 8-h exposure was measured. The concentrate formulation (3 ILl application dispensed from a Hamilton microsyringe) or spray dilution (0.5 ILl application dispensed from a 1-1L1 Hamilton microsyringe) was applied to individual membranes . The receptor fluids used were saline, 50% v/v aqueous ethanol, 6% w/v Volpo 20 in saline, 20% fetal calf serum in saline, and 6% polyethylene glycol (PEG-400) in saline.
In the second series of in vitro experiments, designed to assess the time-related absorption of cypermethrin during a 32-h time period, from the spray dilution formulation through human and rat epidermal membranes, a dose of 5 ILl cm -2 was applied to the skin. The receptor fluids used were 50% v/v aqueous ethanol and 6% w/v Vol po 20 in saline. In both series of experiments frequent receptor samples were taken for radiochemica1 analysis on a BE-TAmatic II (Kontron Instruments, Welwyn Garden City, Herefordshire, U.K.) and dpm values calculated using quench correction data . Results were expressed as percent dose absorbed.
In Vivo Studies The absorption of [14C)cypermethrin from concentrate and spray dilution formulations through skin of the dorsolumbar region of 4-to 5-week-old rats was determined. Fur from the dorsolumbar region was removed using animal clippers 24-30 h before dosing and only animals with clinically normal skin used.
The concentrate formulation (3 ILl) was applied to the shorn backs of lightly anesthetized rats and a plastic guard (completely open to the atmosphere) was glued around the application site using cyanoacrylate ester glue (Loctite, Welwyn Garden City, PERCUTANEOUS ABSORPTION O F CYPERMETHRIN 143 Herts , U.K.). Back scratching was prevented by wrapping rubber tubing around the body as previously described [18] . Each animal was placed in an individual metabolism cage designed for the separate collection of urine and feces . Eight hours after dosing, the rats were humanely sacrificed and blood samples taken by cardiac puncture into lithium heparin tubes. A range of tissues was taken for analysis: liver, both kidneys, and skin from the application site. Residual urine was taken from the bladder and added to the voided urine. The residual carcass was stored at -40°C for later analysis .
In a second series of in vivo experiments designed to determine the tim e course of dermal absorption of cypermethrin from the spray dilution formul ation , 20 ILl of spray dilution formul ation was applied evenly over a predefmed area of 4 cm 2 using a Hamilton microsyringe . Animals (3 rats per group) were sacrificed at 4, 8, 12, and 24 h and samples taken as before.
Sample Preparation Duplicate 0.2-ml aliquots of the urine samples were mixed with 10 ml ofOptiphase "MP" (Fisons pic, Loughborough, U .K .) in plas tic scintillation vials (Packard, Illinois) and the radioactivity determined by liquid scintillation counting.
Skin samples were solubilized in Soluene-350 (Packard) and duplicate weighed samples were mixed with 10 ILl of Dimilume-30 (Packa rd) in glass scintillation vials (Packard) and the radioactivity determined by liquid scintillation counting.
Fecal samples were suspended in methanol and homogenized using an Ultra-Turrax homogeni zer (Sartorius IKA , Belmont, Surrey, U.K.) fitted with a lOS probe. The samples were centrifuged at 1000 g for 10 min in an IEC Centra-7R [Damon/lEC (U .K .) Ltd, Dunstable, Bedfordshire, U.K .] and duplicate 0.2ml aliquots mi xed with 10 ml ofOptiphase " MP " and taken for liquid scintillation counting. The fecal residue was dried and ground to a fine powder using a mortar and pestle.
The individual carcasses were mixed with twice their weight of rat chow and minced to a fine homogenous powder using a Hobart E4522 mincer (Hobart Manufacturing Co Ltd, London, U .K .).
Blood, liver, kidney, g round fecal residue, and carcass were prepared for radiochemical analysis usin g a Packard Tri ca rb 306 sample oxidizer (Packard). The resulting CO 2 was absorbed in 8 ml of Optiphase I (Fisons pic) and admixed with 12 ml of Optiphase "S" scintillant (Fisons pic). Aliquots of[l4C)cypermethrin containing 40,000 dpm were used to determine the overall combustion efficiency.
All sample liquid scintillation counting was done on aBET Amatic II counter with the appropriate quench correction data loaded into the memory of the machine.
RESULTS
Following the in vivo dermal application of the concentrate formulation to the rat, 1.0% (SEM ± 0.4%; n = 3; equivalent to 10.9 ± 4.0 ILg cm -2 cypermethrin) of the total recovered dose was absorbed during the 8-h exposure time.
From the parallel in vitro studies no cypermethrin was abso rbed (limit of determination <0. 1 % of the recovered dose) from either the concentrate or spray dilution, during the 8-h application exposure of whole human or rat skin (Table I) . When rat epidermal membranes were us ed, with 50% aq ueous ethanol, 6% Vol po 20, or 20% fetal calf serum as the receptor fluids, absorption of cypermethrin from both the concentrate and spray dilution formulations was detected. However, absorption was detected only through human epidermal membranes with 50% aq ueous ethanol as the receptor fluid (Table I) . Figure 2 shows the profile of cypermethrin absorption from the in vitro (using 50% aq ueous ethanol and 6% Volpo 20 as the receptor fluids) and in vivo time course study. The in vivo absorption profile was very similar to the in vitro profiles. During the initial 12 h there was no significant difference between the in vivo and in vitro data; however, at 24 h the in vitro experiment using the 6% Volpo 20 recepto r fluid underes timated the in vivo abso rption .
DI SCUS SION
The res ults fr o m the in vivo studies on the percuta neous abso rption of cypermethrin fo rm the bas is fo r comparison w ith the in vitro res ults. The doses selected fo r application to the skin were small and representati ve of the estim ated amounts which could contact workers in no rmal practi ce. M an y in vitro studies have previously been criticized , as the am ounts applied to the skin were excessive compared w ith the prac ti cal in vivo situati o n; this was no t the case in this stud y . By precisely matchin g the applicati ons in vivo and in vitro any di ffe rences detected could no t be ascribed to the app lica ti on regime.
We have considered the chemi cal as percutaneously abso rbed once it has reached the systemic circulation, w hich is located benea th the dermal-epidermal juncti o n. C hemical th at was still on, or in, the skin was not considered as absorbed at the termination of the stud y. In vi vo onl y 1.0% of the applied cyperm ethrin w as absorbed in 8 h following application of the concentrate formul ati on . Altho ugh precise comparisons canno t be m ade due to differences in doses and vehicles, this is low w hen compared to other pesti cides th at have been studied in vivo through human [19] and animal skins [1, 20, 21] .
The epidermal membranes used in these experiments are di fferent fro m skin slices w hich have been used by other workers [6] as they do not contain an y dermis [17] , a barrier to li pophilic molecul es in vitro but not in vivo . The recepto r fluid s were selected both to have a range of solu bility pro perties and to reflect normal body fluid s (saline and fetal calf serum): similar recepro r fluid s have previo usly been used [22] .
Previous percutaneous absorption studies w ith lipo phili c m olecul es have sho w n that in vitro the aqueous dermis can ac t as a signifi ca nt, additional, artificial barrier [8] : penetrating mo lecules enter the sys temic circulation in vivo at the top of the dermis and do not have to traverse its full thi ckness. Other in vitro studies [22] with lipophilic molecules have repo rted poor ag reem ent compared w ith in vivo human data [1 9 ] rather than the good agreement achieved w ith mo re water-soluble mo lecules. The in vitro res ults indica ted lo w er absorption fo r the lipophilic m olecul es th an expected and the res ults were pro bably influenced by the presence of the dermis. As anticipated, the dermis influenced abso rption of cypcrm ethrin in vitro, durin g thc 8-h exposurc time, th ro ug h both hum an and rat w hol e skin (Table I) . Whcn epidermal membranes were uscd, however, we were ab le to quantify thc absorptio n of cypermethrin .
The influence of the dermis as an extra barricr to the abso rptio n of lipop hilic mo lecu les has also been repo rted in in vivo studics w ith hum an sk in transplanted o nto athym ic mou sc skin [23] . Good ag reem ent was seen betwcen the permca bility of th e tran splanted hum an skin and published hum an in vivo data [1 9 ] for water-solubl e chcmi ca ls but poo rer ag reement was seen w ith the more lipophili c mo lecu les. In the gra fted skin, the dcrmis was ab no rm all y thick and poorly vascul ari zed and mig ht have acted as an additi onal barri er to the lipo philic molecul es.
T he necess ity of a suitable reccptor fluid in in vitro percutan eous abso rption assess mcnts has been reported [22] and we have confirmed that the vario us receptor fluids chosen for o ur stud y influ enced the absorptio n of cyperm ethrin . The hi g hest absorption was measured w ith 50% aqueous ethano l as the receptor fluid and, although absorption measurcd with the other two receptor fluids w ith lipid-solubl e properties (6% Volpo 20 and 20% fetal calf seru m) was ve ry similar, no abso rption was detected w ith the other receptor fluid s. These results reinforce the view that the choice of a receptor fluid in w hi ch the penetratin g mol ecule is hi g hl y soluble is necessa ry for successful in vitro meas urements. Otherwise, solubility in th e receptor phase, rather than diffusion thro ugh the epidermis, will be the rate-limiting step .
It is apparent with the concentrate formulation, that there was a similar magnitude of absorption measured in the in vivo experiments and the in vitro experiments (when appropriate skin membrane and suitable recepto r fluid were used). The res ults indicate sl ig htl y g rea ter absorption in vitro than in vivo. The absorption measured in vivo was vcry low and even w ith the use of a radiolabeled molec ul e there arc signifi cant analytic difficulties in o btaining determinations from tissues.
Based on these data, the in vitro absorption of cypermethrin wi th tim e was measured from the spray dilution fo rmulation throug h rat epidermal membran e and 50% aqucous ethanol and 6% Volpo 20 as the receptor fluids . Fetal ca lf serum was not suitable for use over long time periods . The results were compared to data from an equivalent in vivo stud y (Fig 2) . The absorption was greatcr with the 50% aqueous ethanol receptor fluid than with the 6% Volpo 20 in sa linc, altho ug h the abso rption profiles were similar. The in vivo profile showed a good co rrelation w ith th e in vitro profilcs, usin g both receptor fluid s up to 12 h. At 24 h thcrc was still good agrccment between th e in vivo data and in vitro data usin g the 50% aq ueous ethano l as the receptor fluid , but th e res ults with the 6% Vol po 20 recepto r fluid underestimated the in vivo absorption of cypermethrin . A similar in vitro underes tim ation of in vivo absorption, thoug h with a similar absorptio n profile, has been seen with other lipophilic molecules w hen 6% Vol po 20 in sa line was used as the rcceptor fl uid [22] .
These studies have confirmed thc marked species differences in percutaneous absorption that ca n occur. An y assessmcn t o f the percutaneous absorptio n of cypermethrin, using rat skin , w ill lea d to an overestimation of potential human absorption. We ha ve sho w n [2] that not on ly th e rat, but other co mmon laboratory animals, are poor models for hum an skin permea bility , particularl y with slowly absorbed chemica ls. H owever, the in vitro technique provides a method for quantifying the difference in the permeability properties of human and animal skin . T he only data that allow a quantitation of the difference in the permeability of human and rat skin to cypermethrin are those using the spra y di lution , epidermal m embranes, and 50% aqueous ethanol rece ptor fluid. In these experiments, human skin was 24 times less permea ble to cypermethrin than rat skin . With the other receptor fluids used, ifit is assumed that 0. 1 % was actuall y absorbed, these experiments indicate that rat skin is 17-32 times more permeabl e than human sk in .
This study has shown that an understandin g of the technical PERCUTANEOUS ABSORPT IO N OF C YPERMETHRIN 145 difficulti cs and limitations of th e in vitro percutaneous absorption technique allows experim ents to be don e which give data in good ag reement with in vivo data. Once the influen ce of the ty pe of membrane and recep tor fluid are understood , data can be obtained for a wide range o f molecul es w ith different ph ysicochem ical properties . In vitro assess m cnts are less demandin g than in vivo experiments, and furth er understandin g of the in vitro technique should promote its wider acceptance and mi g ht reduce the need for many in vivo studies.
